Found: 30
Select item for more details and to access through your institution.
Iodoacetamide blank compensation in FXIII functional assays: Is it still necessary?
- Published in:
- International Journal of Laboratory Hematology, 2023, v. 45, n. 6, p. 969, doi. 10.1111/ijlh.14111
- By:
- Publication type:
- Article
Applying index of circulating anticoagulant to mixing tests with lupus anticoagulant screen and confirm reagents can distinguish with high specificity between lupus anticoagulants and direct factor Xa inhibitors.
- Published in:
- International Journal of Laboratory Hematology, 2021, v. 43, n. 4, p. 771, doi. 10.1111/ijlh.13571
- By:
- Publication type:
- Article
Paired APTTs of low and high lupus anticoagulant sensitivity permit distinction from other abnormalities and achieve good lupus anticoagulant detection rates in conjunction with dRVVT.
- Published in:
- International Journal of Laboratory Hematology, 2019, v. 41, n. 1, p. 60, doi. 10.1111/ijlh.12921
- By:
- Publication type:
- Article
Anti-platelet factor 4/heparin antibodies from patients with heparin-induced thrombocytopenia provoke direct activation of microvascular endothelial cells.
- Published in:
- International Immunology, 2002, v. 14, n. 2, p. 121, doi. 10.1093/intimm/14.2.121
- By:
- Publication type:
- Article
Serological features of antibodies to protamine inducing thrombocytopenia and thrombosis.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2015, v. 53, n. 2, p. 249, doi. 10.1515/cclm-2014-0664
- By:
- Publication type:
- Article
Analyse des performances analytiques du réactif Hemoclot Protein C Hyphen BioMed sur automate ACL TOP : évaluation en portée B.
- Published in:
- Annales de Biologie Clinique, 2016, v. 74, n. 6, p. 735, doi. 10.1684/abc.2016.1185
- By:
- Publication type:
- Article
Annexin A1 Is Associated with Adverse Clinical Outcomes in Patients with COVID-19.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 24, p. 7486, doi. 10.3390/jcm11247486
- By:
- Publication type:
- Article
Development of IgG, IgM, and IgA Autoantibodies Against Angiotensin Converting Enzyme 2 in Patients with COVID-19.
- Published in:
- 2022
- By:
- Publication type:
- Letter
A very potent factor V inhibitor interferes with the levels of all coagulation factors and causes a fatal hemorrhagic syndrome.
- Published in:
- European Journal of Haematology, 2019, v. 103, n. 2, p. 137, doi. 10.1111/ejh.13249
- By:
- Publication type:
- Article
Prognostic value of increased soluble thrombomodulin and increased soluble E-selectin in ischaemic heart disease.
- Published in:
- European Journal of Haematology, 1997, v. 59, n. 2, p. 115, doi. 10.1111/j.1600-0609.1997.tb00735.x
- By:
- Publication type:
- Article
Hyperhomocyst(e)inemia and endothelial dysfunction in IDDM.
- Published in:
- 1998
- By:
- Publication type:
- journal article
Hyperhomocyst(e)inemia and endothelial dysfunction in IDDM.
- Published in:
- 1997
- By:
- Publication type:
- journal article
Generation of antibodies to heparin-PF4 complexes without thrombocytopenia in patients treated with unfractionated or low-molecular-weight heparin.
- Published in:
- American Journal of Hematology, 1996, v. 52, n. 2, p. 90, doi. 10.1002/(SICI)1096-8652(199606)52:2<90::AID-AJH4>3.0.CO;2-0
- By:
- Publication type:
- Article
Editorial for the Special Issue of Monitoring Anticoagulants.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Optimization of Heparin Monitoring with Anti-FXa Assays and the Impact of Dextran Sulfate for Measuring All Drug Activity.
- Published in:
- Biomedicines, 2021, v. 9, n. 6, p. 700, doi. 10.3390/biomedicines9060700
- By:
- Publication type:
- Article
An Optimized and Standardized Rapid Flow Cytometry Functional Method for Heparin-Induced Thrombocytopenia.
- Published in:
- Biomedicines, 2021, v. 9, n. 3, p. 296, doi. 10.3390/biomedicines9030296
- By:
- Publication type:
- Article
Updates on Anticoagulation and Laboratory Tools for Therapy Monitoring of Heparin, Vitamin K Antagonists and Direct Oral Anticoagulants.
- Published in:
- Biomedicines, 2021, v. 9, n. 3, p. 264, doi. 10.3390/biomedicines9030264
- By:
- Publication type:
- Article
Updates in Anticoagulation Therapy Monitoring.
- Published in:
- Biomedicines, 2021, v. 9, n. 3, p. 262, doi. 10.3390/biomedicines9030262
- By:
- Publication type:
- Article
The Lectin-Like Domain of Thrombomodulin Inhibits β1 Integrin-Dependent Binding of Human Breast Cancer-Derived Cell Lines to Fibronectin.
- Published in:
- Biomedicines, 2021, v. 9, n. 2, p. 162, doi. 10.3390/biomedicines9020162
- By:
- Publication type:
- Article
Unusual Case of HIT With Cardiac Arrest During Hemodialysis.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Evaluation of Immunostimulatory Potential of Branded and US-Generic Enoxaparins in an In Vitro Human Immune System Model.
- Published in:
- Clinical & Applied Thrombosis/Hemostasis, 2015, v. 21, n. 3, p. 211, doi. 10.1177/1076029614562037
- By:
- Publication type:
- Article
Generation and Pathogenicity of Anti-Platelet Factor 4 Antibodies: Diagnostic Implications.
- Published in:
- Clinical & Applied Thrombosis/Hemostasis, 1999, v. 5, n. 1S, p. S28, doi. 10.1177/10760296990050S106
- By:
- Publication type:
- Article
Usefulness of Laboratory Techniques for Evaluating Antithrombotic Efficacy of New Therapeutic Strategies.
- Published in:
- Clinical & Applied Thrombosis/Hemostasis, 1995, v. 1, n. 4, p. 243, doi. 10.1177/107602969500100401
- By:
- Publication type:
- Article
Detecting molecular forms of antithrombin by LC-MRM-MS: defining the measurands.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2018, v. 56, n. 10, p. 1704, doi. 10.1515/cclm-2017-1111
- By:
- Publication type:
- Article
High incidence of anti-heparin/platelet factor 4 antibodies after cardiopulmonary bypass surgery.
- Published in:
- British Journal of Haematology, 1998, v. 101, n. 4, p. 653, doi. 10.1046/j.1365-2141.1998.00750.x
- By:
- Publication type:
- Article
Differences in specificity of heparin-dependent antibodies developed in heparin-induced thrombocytopenia and consequences on cross-reactivity with danaparoid sodium.
- Published in:
- British Journal of Haematology, 1997, v. 99, n. 2, p. 273, doi. 10.1046/j.1365-2141.1997.4183225.x
- By:
- Publication type:
- Article
Circulating endothelial cell/leucocyte adhesion molecules in ischaemic heart disease.
- Published in:
- British Journal of Haematology, 1996, v. 95, n. 2, p. 263, doi. 10.1046/j.1365-2141.1996.d01-1921.x
- By:
- Publication type:
- Article
Pathogenicity of IgA and/or IgM antibodies to heparin-PF4 complexes in patients with heparin-induced thrombocytopenia.
- Published in:
- British Journal of Haematology, 1996, v. 92, n. 4, p. 954, doi. 10.1046/j.1365-2141.1996.407945.x
- By:
- Publication type:
- Article
The influence of age, gender and ABO blood group on soluble endothelial cell markers and adhesion molecules.
- Published in:
- British Journal of Haematology, 1996, v. 92, n. 2, p. 498, doi. 10.1046/j.1365-2141.1996.d01-1486.x
- By:
- Publication type:
- Article
Antiphospholipid antibodies before and after liver transplantation
- Published in:
- American Journal of Gastroenterology (Springer Nature), 2003, v. 98, n. 2, p. 460, doi. 10.1111/j.1572-0241.2003.07220.x
- By:
- Publication type:
- Article